|
"tsai t f"的相關文件
顯示項目 191-200 / 226 (共23頁)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T05:29:52Z |
Role of breast tumour kinase in the in vitro differentiation of HaCaT cells
|
Wang, T.C.;Jee, S.H.;Tsai, T.F.;Huang, Y.L.;Tsai, W.L.;Chen, R.-H.Wang, Tsun-Cheng;Jee, Shiou-Hwa;Tsai, Tsen-Fang;Huang, Yi-Ling;Tsai, Wei-Ling;Chen, Ruey-Hwa王敦正;紀秀華;蔡呈芳;黃懿鈴;蔡偉玲;陳瑞華; WANG, TSUN-CHENG; SHIOU-HWA JEE; JEE, SHIOU-HWA; TSEN-FANG TSAI; TSAI, TSEN-FANG; HUANG, YI-LING; TSAI, WEI-LING; CHEN, RUEY-HWA |
| 臺大學術典藏 |
2018-09-10T05:00:12Z |
Epstein-Barr virus-associated lymphoproliferative disorder of granular lymphocytes presenting initially as cutaneous vasculitis
|
Tsai, T.-F.;Chen, R.-L.;Su, I.-J.;Jee, S.-H.;Tien, H.-F.; SHIOU-HWA JEE |
| 臺大學術典藏 |
2018-09-10T04:15:54Z |
HLA-Cw6 specificity and polymorphic residues are associated with susceptibility among Chinese psoriatics in Taiwan
|
Tsai, T.-F.;Hu, C.-Y.;Tsai, W.-L.;Chu, C.-Y.;Lin, S.-J.;Liaw, S.-H.;Chiang, B.-L.;Lin, P.-J.;Jee, S.-H.; SHIOU-HWA JEE |
| 臺大學術典藏 |
2018-09-10T04:07:10Z |
The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells
|
YI-HUA LIAO; CHIA-YU CHU; TSEN-FANG TSAI; SHIOU-HWA JEE; Jee, S.H.;Chiu, H.C.;Tsai, T.F.;Tsai, W.L.;Liao, Y.H.;Chu, C.Y.;Kuo, M.-L. |
| 臺大學術典藏 |
2018-09-10T04:07:02Z |
Multiple Epstein-Barr virus-associated subcutaneous angioleiomyomas in a patient with acquired immunodeficiency syndrome
|
Chang, J.Y.-F.;Wang, C.-S.;Hung, C.-C.;Tsai, T.-F.;Hsiao, C.-H.; JULIA YU-FONG CHANG; TSEN-FANG TSAI; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2018-09-10T03:31:17Z |
Effects of glycolic acid on light-induced skin pigmentation in Asian and Caucasian subjects
|
Tsai, T.-F.;Bowman, P.H.;Jee, S.-H.;Maibach, H.I.; SHIOU-HWA JEE |
| 臺大學術典藏 |
2018-09-10T03:31:17Z |
Erratum: Effects of glycolic acid on light-induced skin pigmentation in Asian and Caucasian subjects (Journal of the American Academy Dermatology (August 2000) 43 (283-243))
|
Tsai, T.-F.;Paul, B.H.;Jee, S.-H.;Maibach, H.I.; SHIOU-HWA JEE |
| 國立臺灣大學 |
2016 |
Secukinumab demonstrates an acceptable safety profile in moderate to severe plaque psoriasis: Pooled analysis of 10 phase 2/3 studies
|
Foley, P.; Griffiths, C.; Reich, K.; Leonardi, C. L.; Blauvelt, A.; Mehta, N. N.; Tsai, T. F.; Gong, Y.; Papavassilis, C.; Huang, J.; Fox, T.; van de Kerkhof, P.; 蔡呈芳 |
| 國立臺灣大學 |
2016 |
Secukinumab delivers greater improvement in health-related quality of life compared to ustekinumab in subjects with moderate to severe plaque psoriasis: 16-week data from the CLEAR study
|
Rubel, D.; Thaci, D.; Blauvelt, A.; Reich, K.; Tsai, T. F.; Vanaclocha, F.; Kingo, K.; Ziv, M.; Pinter, A.; Hugot, S.; You, R.; Augustin, M.; Milutinovic, M.; 蔡呈芳 |
| 國立交通大學 |
2015-12-02T02:59:19Z |
Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study
|
Chiu, H-Y; Huang, H-L; Li, C-H; Yin, Y-J; Chen, H-A; Hsu, S-T; Lin, S-J; Tsai, T-F; Ho, S-Y |
顯示項目 191-200 / 226 (共23頁)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
每頁顯示[10|25|50]項目
|
